About the job
Amylyx Pharmaceuticals is dedicated to pioneering a new era in the treatment of diseases that present significant unmet needs. Where others see obstacles, we identify opportunities, pursuing them with urgency, robust scientific methods, and an unwavering commitment to the communities we serve. As a clinical-stage company, we are currently focusing on post-bariatric hypoglycemia (PBH), Wolfram syndrome, and amyotrophic lateral sclerosis (ALS).
Our mission is driven by our exceptional team. We uphold core values of boldness, curiosity, authenticity, engagement, and accountability, fostering a culture of compassion. At Amylyx, we have brought together an experienced group ready to act, as the communities we support cannot afford to wait. If you are passionate and determined to confront some of the toughest challenges in medicine, we invite you to explore this exciting opportunity and consider applying.
The Opportunity
Amylyx is on the lookout for a Director of Launch Excellence who will be instrumental in orchestrating the planning and execution of our inaugural product launch in the endocrinology sector. This important role will be filled in 2026, collaborating across various functions to ensure readiness for a potential product launch in 2027.
The Director of Launch Excellence will act as the primary coordinator for all launch activities, ensuring disciplined execution, clear ownership, and visibility across Commercial, Medical, Clinical, Regulatory, Manufacturing, Market Access, Finance, Legal, and IT. This is a hands-on position requiring excellent project leadership, sound judgment, and the ability to thrive in a rapidly evolving biotech environment.

